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Objective.Thecharacteristicsoforallichenplanus(OLP)provokeinvestigatorstoexplorepossiblebiomarkersbywhichtomonitor
disease activity and therapeutic eﬃcacy. Oral ﬂuids may provide an accessible medium for analysis of such biomarkers. Previous
studies have shown that activation of nuclear factor-kappa B (NF-κ B) plays an important role in the pathogenesis of oral lichen
planus (OLP), which is a chronic inﬂammatory disorder mediated by T cells. Prior to the present investigation, reports of the
levels of NF-κ B and its dependent cytokines in oral ﬂuids have not been forthcoming. The purpose of this study was to detect
the level of NF-κ B dependent cytokines, TNF-alpha, IL-1-alpha, IL-6, and IL-8 in tissue transudates directly from lesions of OLP,
and explore the feasibility of the data for clinical application. Study design. Thirteen deﬁnitively diagnosed OLP subjects were en-
rolled in the study as were 13 age-sex matched controls. In each subject, lesion tissue transudates (TTs) were collected by a novel
collection technique with a ﬁlter paper. The level of cytokines, TNF-alpha, IL-1-alpha, IL-6, and IL-8 in three types of oral ﬂuids
were determined by ELISA. Results. In the tissue transudate(TT), there were signiﬁcantly higher level of cytokines TNF-alpha,
IL-1-alpha, IL-6, and IL-8 detected in OLP patients than in controls: (TT: 40.0 ± 9.8v e r s u s4 .5 ± 0.7, 710 ± 114 versus 305 ± 78,
150 ± 25 versus 1.7 ± 0.5, 2800 ± 260 versus 1450 ± 130, P<. 0001; unit: pg/mL). Conclusions. These results indicate that NF-κ B
dependent inﬂammatory cytokines may be detected at increased levels in oral lesion tissue transudates which may have diagnostic
and prognostic potentials for monitoring disease activity and making therapeutic decisions in patients with OLP.
Copyright © 2007 Nelson L. Rhodus et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Evidence from investigations using mouse and human mod-
els has indicated that T helper cells can be classiﬁed into at
least two functional subsets, Th1 and Th2, on the basis of
their cytokine proﬁles. Th1 cells were characterized by the
production of IL-2, IFN-γ and TNF-β a n dw e r ec r i t i c a li n
thecell-mediatedimmunity,butTh2cellswerecharacterized
by the production of IL-4, IL-5, IL-6, and IL-13 and played
an important role in humoral immunity. These two Th sub-
sets regulated each other’s function through the antagonis-
tic activity of their respective cytokines which determined in
large extent the characteristics of immune responses and de-
velopments [1, 2]. Many studies have demonstrated a close
relationship between Th1/Th2 imbalance and pathogenesis
of a series of autoimmune disorders including Behcet’s dis-
ease (Th1 dominant response), Sjogren syndrome secondary
to hepatitis C virus infection (Th2 dominant response), pso-
riasis (Th1dominant response),andothers [3–5].Increasing
evidences showed that the balance of immune responses be-
tween Th1 and Th2 determined outcomes of diseases and
modulation of Th1/Th2 imbalance became a new therapeu-
tic strategy of some autoimmune diseases, for example, IL-4
in psoriasis, anti-CD4 monoclonal antibody in experimen-
tal arthritis, and IFN-γ in corticosteroids-resistant asthma
[6–8].
Oral Lichen planus (OLP) is a chronic inﬂammatory dis-
order characterized by a T-cell-mediated immune response
against epithelial cells, with persistent accumulation of T
lymphocytes and epithelial cell damage. Previous studies
have described the expression pattern of the diﬀerent cy-
tokines/chemokines, which involved in Th1 and/or Th2 po-
larization, in tissues, cultured cells, and serum from patients
with OLP, including IL-2 [9–11], IFN-alpha [11–14], TNF-
alpha [9,11,12,15–18],IL-4[9,12,18],IL-6[11,13,18,19],
IL-10 [9, 12, 18], and TGF-alpha [9, 12, 20], IL-1 [18], IL-
8[ 21, 22]. From these results, Sugerman et al. concluded
that OLP was characterized by Th1 cytokine bias [23]. This2 Mediators of Inﬂammation
conclusion has not been supported by the study on Th1/Th2
cytokineratioinOLP,oneofthedirectindicatorsofTh1/Th2
imbalance.
In this small pilot study, our focus was on the shift
of TNF-alpha/IL-6, IL-1/IL-6, and IL-8/IL-6 ratio in tissues
transduates (TT) of OLP subjects, one of the diagnostic me-
diumsreﬂectingexactlylocalimmuneresponseoforalcavity.
2. MATERIALS AND METHODS
2.1. Theclinicopathologicaldataofsubjects
All subjects were from the University of Minnesota Oral
Medicine Clinic and Hospital of Stomatology, Sun Yat-Sen
University. With the approval of the Committee for the Use
of Human Subjects in Research, informed consent was ob-
tained from all subjects.
ThirteenpatientsclinicallydiagnosedasOLP[24]and13
age-sex matched healthy individuals were recruited for the
study. They had to comply with the following criteria: (1) the
absenceofanydetectablegingivaland/orperiodontalinﬂam-
mation and other visible oral lesions, (2) the absence of his-
tory of local and systematic diseases, (3) the absence of med-
ication record, for example, anticholinergics, antihistamines,
antihypertensives, beta-adrenergic blockers, and other regi-
men inducing hyposalivation, and (4) the absence of previ-
ous or current treatment. Their characteristics were listed in
Table 1.
Thebiopsywastakenfromeachpatient,followingcollec-
tionoforalﬂuids,andthetissuespecimenswereprocessedby
the Department of Oral Pathology at both universities. The
pathologic diagnosis conﬁrmed by two oral pathologists in-
dependently was consistent with clinical diagnosis.
2.2. Collectionoftissuetransudates
The lesion tissue transudates (TT) were collected by a modi-
ﬁedtechnique[25].Brieﬂy,theTTwascollectedafterslightly
drying the OLP lesion area and then by placing a Periopaper
strip directly over the area for 30 seconds. In control group,
theTTwascollectedbythe samemethodonthe correspond-
ing anatomic site. The volume of TT was quantiﬁed on the
Periotron (Harco, Tustin, Calif, USA) and the paper strips
were placed in 1.5mL micropipette tubes containing 1mL
of saline solution. After collection, all samples were immedi-
ately stored at −20◦C until assayed.
2.3. Detectionofcytokines
Priortoanalysis,asamplefromthepaperstripswaselutedby
3 serial centrifuge extractions, each using 1mL of PBS buﬀer
solution at 10 000rpm for 30 seconds, and was combined
with the saline which the paper strips were initially stored in
immediately after collection.
Then all samples were thawed on ice in the lab and were
centrifuged at 6 000rpm for 20 minutes. Supernatants were
drawn oﬀ and used in the ELISA cytokine assays. For Each
sample, 100μL supernatant was used for these assays.
Table 1: Clinical features of subjects.
OLP (n = 13) Control (n = 13)
Age (y)
Mean ± SD 57 ±11 58 ±12
Range 42 ∼ 68 40 ∼ 74
Gender
F/M 13/0 13/0
Clinical classiﬁcation
Erosive 9 —
Reticular and/or plaque-like 2 —
Atrophic 2 —
Site
Buccal mucosa 11 —
Buccal mucosa and gingiva 2 —
Histological classiﬁcation
OLP 12 —
OLP and mild dysplasia 1 —
TNF-alpha, IL-1-alpha IL-6, and IL-8 concentrations
were determined by the quantitative sandwich ELISA
technique as previously described [26], using commercially
available kits (R&D Systems Inc., Minneapolis, Minn,
USA) with a sensitivity of less than 3pg/mL. Brieﬂy, Costar
96-well EIA Plates were coated with a 1 : 1000 dilution of
1mg/mL anti-IgA (Dako). Plates were incubated overnight.
Standards, samples, and blanks were incubated for 2 hours.
Sample dilutions ranged from 1 : 50000 to 1 : 200000 and
standardsrangedfrom0.5to10ng/mL(Sigma).Biotinylated
antibodies for each cytokine were incubated for 2 hours.
Avidin-alkaline phosphatase conjugate (Organon Teknika,
The Netherlands) was incubated for 2 hours. Phosphatase
substrate was added and was allowed to develop for 30
minutes in the dark and reaction was stopped with 1mol/L
NaOH. All incubations were at 37◦C. All plates were washed
between each step with PBS-Tween wash buﬀer. Absorbance
was measured at 450nm using software from the Molecular
Devices Corporation. The standard curves were plotted on
a log-log scale. Sample concentrations were determined by
linear regression of log average column absorbance against
log standard concentration. R-squared values for typical
log-log standard curves were >0.98; column coeﬃcients of
variation ranged between 10%–20%. Correlations between
sample dilutions were >0.90.
2.4. Statistics
Data were expressed as mean ± standard deviation (SD).
Since it was not clear whether the data were distributed
normally, the test of data normality (Shapiro-Wilk test),
Mann-Whitney test, and independent-samples t test were
performed, respectively. P<. 05 was considered to be
statistically signiﬁcant. Statistical Package for Social Studies
(SPSS, Version 11.0, SPSS Inc., Chicago, Ill, USA) software
was used to analyze the data.Nelson L. Rhodus et al. 3
Table 2: The Levels of four cytokines in TT from subjests (pg/mL).
Group TNF-alpha IL-1-alpha IL-6 IL-8
OLP (n = 13) 40.0 ±9.8 710 ±114 150 ±25 2800 ±260
C( n = 13) 4.5 ±0.7 305 ±78 1.7 ±0.5 1450 ±130
t value 13.23 10.60 21.44 16.80
P value <. 0001 <. 0001 <. 0001 <. 0001
Table 3: Th1/Th2 cytokine ratio in TT.
Group TNF-alpha /IL-6 IL-1/IL-6 IL-8/IL-6
OLP (n = 13) 0.3 ±0.14 .8 ±0.91 9 ±3
C( n = 13) 3.0 ±1.0 200 ±78 947 ±273
t value 9.671 9.034 12.255
P value .0001 .0001 .0001
3. RESULTS
All data were conﬁrmed to be normal distribution by
Shapiro-Wilk test. The same results were obtained from both
nonparametric and parametric tests. The statistical results of
independent-samples t test were presented in Tables 2 and 3.
4. DISCUSSION
The Th1/Th2 balance hypothesis emerged in the late 1980s.
Currently, much of the literatures have elevated the Th1/Th2
balance concept to the level of paradigm, moreover cytokine
and anticytokine therapies, derived from the concept of
modulating Th1/Th2 imbalance, have been successfully ap-
plied to several autoimmune diseases [27], including Sjo-
gren syndrome [28, 29], psoriasis [6], and corticosteroids-
resistant asthma [8]. Yet some observations indicated that
addressing the role of individual cytokines during immune
response may be far more informative than using the blanket
Th1/Th2 descriptors [2]. In OLP, an inﬂammatory oral mu-
cosal disorder mediated by T cells, however, several lines of
studies on individual cytokines introduced above seem not
able to outline the general immune response in OLP and not
to give some new insights into the therapy strategy of OLP so
thattheapplicationofcytokineandanticytokinetherapiesto
OLP seems to have long way to go. Thus, it is necessary to in-
vestigate the possible Th1/Th2 pattern in OLP which will be
beneﬁcial to its treatment.
Traditionally, IL-2 and IFN-γ, IL-4 and IL-5 were clas-
siﬁed into Th1 cytokine and Th2 cytokines, respectively. As
more and more cytokines have been described and charac-
terized, some cytokines that were not necessarily secreted by
CD4+ TcellspromotedthedevelopmentofeitherTh1orTh2
cells [2]. For example, TNF-alpha, IL-1, and IL-8 as Th1-
associated cytokines and IL-6 as Th2-associated cytokines
have been assigned in some investigations [30, 31]. In this
preliminary study, TNF-alpha, IL-1, IL-8, and IL-6 were as-
signed to Th1 and Th2 cytokines, respectively. The level of
TNF-alpha, IL-1-alpha, IL-6 and IL-8 in TT of OLP patients
and normal controls was determined. Our results showed
that the concentration of TNF-alpha, IL-1-alpha, IL-6, and
IL-8 was signiﬁcantly higher in TT of OLP patients than in
that of controls, furthermore all ratios of cytokines, TNF-
alpha/IL-6,IL-1/IL-6,andIL-8/IL-6inOLPpatientswerede-
creasedsigniﬁcantly,comparedwiththatofcontrols.Thisre-
sult is, to our knowledge, the ﬁrst to suggest the presence of
a Th2 cytokine-dominant condition in these limited subjects
of OLP. Since previous studies indicated Th1 cytokine bias in
OLP [23], it seems to be necessary to evaluate carefully the
published data before a conclusion will be made.
In the past analysis on simultaneous expression of Th1
and Th2 cytokines, Simark-Mattsson et al. noted that cells
expressing mRNA for IL-2, IL-4, IL-10, TNF-α,a n dT G F -
beta 1 were found in all the biopsies studied, and message
for IFN-γ and IL-10 was detected in the cultured T-cell lines
of all the patients [9]. Fayyazi et al. revealed the coexpres-
sion of IFN-γ and IL-6 mRNA in the upper subepithelial
connective tissue and basal and suprabasal keratinocytes of
altered skin/oral mucosa [13]. Khan et al. reported that un-
stimulated OLP lesional T cells secreted IFN-γ in vitro but
IL-4, IL-10, and TGF-beta 1 secretion were not detected
[12]. Yamamoto et al. detected increase of IL-4 and TNF-
alpha in serum from about one third of the patients, and
IL-6 in all patients [11, 32], and they also found that more
IFN-alpha, IL-6, and TNF-alpha were generated by tissue-
inﬁltrating mononuclear cells (TIMCs) of OLP, compared to
TIMC from the chronically inﬂamed gingivae [17]. But these
studies had not calculated and compared the Th1/Th2 cy-
tokine ratio, the direct evidence of Th1/Th2 balance, in OLP.
Similarly,ourdetectionalsoshowedthesimultaneousar-
gumentation of TNF-alpha, IL-1-alpha, IL-8, and IL-6 in TT
of OLP patients. However, the decreased ratio of cytokines,
TNF-alpha/IL-6, IL-1/IL-6, and IL-8/IL-6, was measured in
OLP patients. It may be attributed to the reason that the in-
crease of IL-6 was far more extent than that of TNF-alpha,
IL-1-alpha, IL-8 as seen in Table 2. This result indicated the
possibility that a Th2-dominated immune response does oc-
curinasubgroupofOLPpatients.Moreover,TTwasselected
as an analytic medium in our study. With the advantages
of safety, minimal invasion, and easy access, several types of
body ﬂuids have been applied to a lot of cytokines analyses
in clinical and experimental studies, including bronchoalve-
olar lavage [33, 34], urine [35], synovial ﬂuid [36, 37], and
saliva [38, 39]. Since a series of cytokines produced in tis-
sues of OLP through autocrine and paracrine processes plays
important roles in the local inﬂammatory response of OLP
[23], the collection and analysis of TT will avoid the interfer-
enceofsubclinicalinﬂammatorylesionsoforal-facialregion.
The results from TT analysis may more exactly reﬂect the lo-
cal immune situation of OLP lesion than that from whole
saliva, gingival crevicular ﬂuid, and other oral ﬂuids. There-
fore, our ﬁndings presented here did give the evidence that a
Th2 cytokine-dominanted immune response exists in some
c a s e sw i t hO L P .
In summary, our study, together with the previous re-
ports, indicated that the diﬀerent patterns of Th1/Th2 im-
balance, Th1 or Th2 overactivation or mixed Th1/Th2 con-
ditions,mayoccurinthepathogenesisofOLP.Thelargescale
ofpatientsandmoretypesofcytokinesshouldbeincludedin4 Mediators of Inﬂammation
the future researches before the available results will be used
in monitoring disease activity and direction of OLP therapy.
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